Integrase strand transfer inhibitors and neuropsychiatric adverse events in a large prospective cohort
Author:
Cuzin Lise12ORCID, Pugliese Pascal3, Katlama Christine45, Bani-Sadr Firouzé67, Ferry Tristan89, Rey David10, Lourenco Jeremy11, Bregigeon Sylvie12, Allavena Clotilde1314, Reynes Jacques1516, Cabié André117, Drobacheff-Thiébaut C, Foltzer A, Bouiller K, Hustache-Mathieu L, Chirouze C, Lepiller Q, Bozon F, Babre O, Muret P, Laurichesse H, Lesens O, Vidal M, Mrozek N, Aumeran C, Baud O, Corbin V, Letertre P, Casanova S, Jacomet C, Hoen B, Lamaury I, Fabre I, Curlier E, Ouissa R, Schepers K, Herrmann-Storck C, Dournon N, Merrien D, Perré P, Guimard T, Bollangier O, Leautez S, Morrier M, Ader F, Biron F, Boibieux A, Cotte L, Ferry T, Miailhes P, Perpoint T, Roux S, Degroodt S, Brochier C, Valour F, Chidiac C, Dhiver C, Mokhtari M Saadia, Ménard A, Dupont H Tissot, Toméi C, Meddeb L, Belkhir A Y, Ravaux I, Brégigeon S, Zaegel-Faucher O, Obry-Roguet V, Orticoni M, Soavi M J, Luquet-Besson I, Ressiot E, Carta-Padovani M, Ducassou M J, Bertone H, Galie S, Galinier A, Monclar M, Ritleng A S, Ivanova A, Blanco-Betancourt C, Lions C, Poizot-Martin I, Abel S, Césaire R, Cuzin L, Santos G Dos, Fagour L, Illiaquer M, Najioullah F, Nguyen D, Ouka M, Pierre-François S, Pasquier J, Pircher M, Rozé B, Cabié A, Atoui N, Moing V Le, Makinson A, Meftah N, de Boever C Merle, Montes B, Ferrer A Montoya, Reynes J, André M, Boyer L, Bouillon M P, Delestan M, May T, Allavena C, Bernaud C, Billaud E, Biron C, Bonnet B, Bouchez S, Boutoille D, Brunet-Cartier C, Hall N, Jovelin T, Morineau P, Reliquet V, Hue H, Sécher S, Cavellec M, Soria A, Ferré V, André-Garnier E, Rodallec A, Guen L Le, Lefebvre M, Grossi O, Point P, Aubry O, Khatchatourian L, Raffi F, Pugliese P, Breaud S, Ceppi C, Courjon J, Cua E, Cottalorda J, Dellamonica P, Demonchy E, Monte A De, Durant J, Etienne C, Ferrando S, Fuzibet J G, Garraffo R, Joulie A, Risso K, Mondain V, Naqvi A, Oran N, Perbost I, Pillet S, Prouvost-Keller B, Pradier C, Wehrlen-Pugliese S, Rio V, Rosenthal E, Sausse S, Zouzou G, Hocqueloux L, Cheret A, Goujard C, Quertainmont Y, Teicher E, Lerolle N, Vittecoq D, Deradji O, Fourreau F, Pallier C, Barrail-Tran A, Landman R, Joly V, Rioux C, Lariven S, Gervais A, Lescure F X, Matheron S, Louni F, Godard C, Julia Z, Chansombat M, Rahli D, Mackoumbou-Nkouka C, Charpentier C, Descamps D, Peytavin G, Yazdanpanah Y, Consigny P H, Cessot G, Bossi P, Goesch J, Gilquin J, Benabdelmoumen G, Lanternier F, Charlier C, Amazzough K, Henry B, Pilmis B, Rouzaud C, Morgand M, Touam F, Louisin C, Duvivier C, Lortholary O, Guery R, Danion F, Lourenco J, Parize P, Etienne N, Launay M, Rouzioux C, Avettand Fenoel V, Valantin M A, Flandre P, Caby F, Tubiana R, Agher R, Seang S, Schneider L, Palich R, Blanc C, Katlama C, Berger J L, N’Guyen Y, Lambert D, Lebrun D, Kmiec I, Hentzien M, Brodard V, Bani-Sadr F, Botelho-Nevers E, Gagneux-Brunon A, Frésard A, Lucht F, Fischer P, Partisani M, Cheneau C, Priester M, Batard M L, Bernard-Henry C, de Mautort E, Rey D, Alvarez M, Biezunski N, Debard A, Delpierre C, Lansalot P, Lelièvre L, Martin-Blondel G, Metsu D, Piffaut M, Porte L, Saune K, Delobel P, Ajana F, Alcaraz I, Baclet V, Boucher A, Choisy P, Huleux T, Lafon-Desmurs B, Melliez H, Meybeck A, Pasquet A, Pradier M, Robineau O, Viget N, Valette M,
Affiliation:
1. Infectious and Tropical Diseases, Martinique University Hospital, Fort-de-France, France 2. INSERM UMR1027, Toulouse University, Toulouse, France 3. Infectious Diseases Department, Nice University Hospital, Nice, France 4. Sorbonne Univ., UPMC Univ Paris 06-UMR_S 1136, Pierre Louis Institute of Epidemiology and Public Health, Paris, France 5. AP-HP, Infectious Diseases Department, APHP Pitié Salpêtrière Hospital, Paris, France 6. Reims Champagne-Ardenne University, EA-4684/SFR CAPSANTE, Reims, France 7. Tropical and Infectious Diseases Department, University Hospital Reims, Reims, France 8. Infectious Disease Unit, Hospices Civils de Lyon, Lyon, France 9. Claude Bernard Lyon 1 University, CIRI, INSERM U1111, Lyon, France 10. HIV Infection Care Centre, University Hospital, Strasbourg, France 11. Infectious Diseases Department, AP-HP-Necker Hospital, Paris, France 12. Aix Marseille University, APHM Sainte-Marguerite, Marseille, France 13. Infectious Diseases Department, Nantes University Hospital, Nantes, France 14. UIC 1413 INSERM, Nantes, France 15. Infectious Diseases Department, Montpellier University Hospital, Montpellier, France 16. INSERM U1175, IRD UMI233, Montpellier University, Montpellier, France 17. INSERM CIC1424, Fort-de-France, France
Publisher
Oxford University Press (OUP)
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology,Microbiology (medical)
Reference24 articles.
1. Dolutegravir versus raltegravir in antiretroviral-experienced, integrase-inhibitor-naive adults with HIV: week 48 results from the randomised, double-blind, non-inferiority SAILING study;Cahn;Lancet,2013 2. Dolutegravir in antiretroviral-experienced patients with raltegravir- and/or elvitegravir-resistant HIV-1: 24-week results of the phase III VIKING-3 study;Castagna;J Infect Dis,2014 3. Safety and efficacy of dolutegravir in treatment-experienced subjects with raltegravir-resistant HIV type 1 infection: 24-week results of the VIKING Study;Eron;J Infect Dis,2013 4. Once-daily dolutegravir versus twice-daily raltegravir in antiretroviral-naive adults with HIV-1 infection (SPRING-2 study): 96 week results from a randomised, double-blind, non-inferiority trial;Raffi;Lancet Infect Dis,2013 5. Dolutegravir plus abacavir-lamivudine for the treatment of HIV-1 infection;Walmsley;N Engl J Med,2013
Cited by
43 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
|
|